Axe Compute(NASDAQ) AGPU

Current Price$9.80

Market Cap$99.16M

Since IPO (2010)-100%

5 Year-98%

1 Year-27%

1 Month+22%

Axe Compute last closing stock price
Metric	Price	Date
Last close	USD 8.71	2026-07-20

Axe Compute stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+24.25%	USD 7.01	2026-07-13
1 month	+22.33%	USD 7.12	2026-06-18
3 month	+78.48%	USD 4.88	2026-04-21
Year to date	+21.82%	USD 7.15	2025-12-31
1 year	-26.5%	USD 11.85	2025-07-18
3 year	-90.09%	USD 87.90	2023-07-21
5 year	-97.64%	USD 369.00	2021-07-21
Since inception	-100%	USD 843,644.54	2010-04-09

Axe Compute Financials at a Glance

Market Cap

$99.16M

Revenue (TTM)

$50.29K

Net Income (TTM)

-$238.36M

EPS (TTM)

-$147.99

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$9.80

Volume

675,412.461

Open

$8.60

Price

$9.80

Volume

675,412.461

Open

$8.60

Previous Close

$8.71

Daily Range

$8.60 - $10.00

52-Week Range

$1.03 - $32.10

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.30 (Average)

Price

$9.80

Volume

675,412.461

Open

$8.60

Previous Close

$8.71

Daily Range

$8.60 - $10.00

52-Week Range

$1.03 - $32.10

Estimated Earnings Date

Aug 6, 2026

AGPU News

POAI Reports Earnings

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Axe Compute

Axe Compute helps companies access powerful computer resources for artificial intelligence projects. It also uses artificial intelligence to support cancer drug research. Its services aim to make complex computing and medical research more efficient for businesses and scientists.

What’s in the Toolbox? Axe Compute’s Main Offerings

Compute Services: On-demand access to high-performance graphics processing units (GPUs) for artificial intelligence workloads; 0% of 2025 revenue.
Treasury Management: Acquisition and management of Aethir (ATH) digital tokens for asset growth; 0% of 2025 revenue.
Drug Discovery Services: Artificial intelligence-driven drug research using a large tumor sample biobank; 100% of 2025 revenue.
Clinical Diagnostics: Testing for gynecological cancers through subsidiary Helomics; included in Drug Discovery Services revenue.
Discontinued Medical Devices: Automated fluid waste management systems (STREAMWAY), sold in March 2025; contributed revenue before sale.

Growth and Expansion: The Axe Compute Adventure

Sold the Eagan segment (STREAMWAY System) in March 2025 to focus on core services.
Launched digital asset treasury strategy with Aethir tokens in September 2025.
Raised $343.5 million through two PIPE transactions in October 2025, including cash and discounted ATH tokens.
Announced strategic review of legacy drug discovery business in February 2026.
Signed first GPU compute service contracts with enterprise clients in March 2026.

Why Axe Compute Stands Out (Without the Hype)

Axe Compute uses a distributed model, offering GPU power without owning data centers. Its partnership with the Aethir network links computing revenue to digital asset holdings. The company’s large tumor biobank supports unique artificial intelligence-driven drug research.

Five Things You Need to Know

Revenue was $125,284 in 2025, up 47.7% from 2024.
Net loss was $(233.1) million in 2025, compared to $(12.7) million in 2024.
Operating loss was $(180.9) million in 2025, up from $(10.3) million in 2024.
Cash and cash equivalents were $10.8 million as of December 31, 2025.
Digital asset holdings (ATH tokens) were valued at $24.4 million at year-end 2025.

Bottom Line

Axe Compute has shifted from medical devices and drug research to focus on digital asset-based computing. The company’s evolution highlights adaptability and a willingness to pursue new business models.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

CEO

Christopher Miglino

Website

predictive-oncology.com

Headquarters

Pittsburgh, PA 15201, US

AGPU Financials

Key Financial Metrics (TTM)

Gross Margin

-325.17%

Operating Margin

-58805.87%

Net Income Margin

-474020.63%

Return on Equity

-10705.18%

Return on Capital

-57.56%

Return on Assets

-527.08%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$99.16M

Shares Outstanding

11.38M

Volume

675.41K

Avg. Volume

1.75M

Financials (TTM)

Gross Profit

-$163.51K

Operating Income

-$29.57M

EBITDA

-$237.72M

Operating Cash Flow

-$12.47M

Capital Expenditure

-$21.00K

Free Cash Flow

-$12.49M

Cash & ST Invst.

$6.93M

Total Debt

$1.43M

Axe Compute Performance Analysis

Axe Compute annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 1,505,459	6.0%
2023	2023-12-31	USD 1,627,697	8.1%
2024	2024-12-31	USD 84,812	-94.8%
2025	2025-12-31	USD 125,284	47.7%

Axe Compute sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-97.6%
Q3	2025-09-30	34.9%
Q4	2025-12-31	139.7%
Q1	2026-03-31	307.1%

Axe Compute annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -105.77	-1.6%
2023	2023-12-31	USD -52.25	-50.6%
2024	2024-12-31	USD -33.56	-35.8%
2025	2025-12-31	USD -13.36	-60.2%

Axe Compute sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	32.4%
Q3	2025-09-30	-46530.4%
Q4	2025-12-31	65.5%
Q1	2026-03-31	99.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$35.31K

-68.0%

Gross Profit

-$150.98K

-331.6%

Gross Margin

-4.28%

N/A

Market Cap

$99.16M

N/A

Market Cap/Employee

$7.08M

N/A

Employees

N/A

Net Income

-$7.71M

-215.6%

EBITDA

-$7.53M

-255.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.93M

+124.3%

Total Debt

$1.43M

-25.3%

Accounts Receivable

$10.10M

+16774.9%

Inventory

$0.00

-100.0%

Long Term Debt

$724.54K

-48.4%

Short Term Debt

$707.68K

+37.9%

Return on Assets

-5.27%

N/A

Return on Invested Capital

-72.13%

N/A

Free Cash Flow

-$3.77M

-398.1%

Operating Cash Flow

-$3.75M

-395.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CYCNCyclerion Therapeutics, Inc.

CYCNCyclerion Therapeutics, Inc.$3.81+1.60%

MYNZMainz Biomed B.V.

MYNZMainz Biomed B.V.$3.59+0.84%

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.86+6.20%

BNGOBionano Genomics, Inc.

BNGOBionano Genomics, Inc.$1.13+0.44%

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$2.51-2.33%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.12+4.43%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.45-4.08%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

VIVKVivakor

VIVKVivakor$5.49+2.17%

UTZUtz Brands

UTZUtz Brands$14.12+0.89%

AALAmerican Airlines Group

AALAmerican Airlines Group$15.28+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$17.44+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.37+0.06%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$34.83+0.23%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$6.25+0.25%

Questions About AGPU

What is the current price of Axe Compute?

Axe Compute is trading at $9.80 per share.

What is the 52-week range for Axe Compute?

Over the past 52 weeks, Axe Compute has traded between $1.03 and $32.10.

How much debt does Axe Compute have?

As of the most recent reporting period, Axe Compute reported total debt of $1.43M.

How much cash does Axe Compute have on hand?

Axe Compute reported $6.93M in cash and cash equivalents in its most recent financial results.

What is Axe Compute’s dividend yield?

Axe Compute does not currently have a dividend yield.

Axe Compute(NASDAQ) AGPU

Axe Compute Financials at a Glance

AGPU News

POAI Reports Earnings

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Axe Compute

What’s in the Toolbox? Axe Compute’s Main Offerings

Growth and Expansion: The Axe Compute Adventure

Why Axe Compute Stands Out (Without the Hype)

Five Things You Need to Know

Bottom Line

AGPU Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Axe Compute Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AGPU

What is the current price of Axe Compute?

What is the 52-week range for Axe Compute?

How much debt does Axe Compute have?

How much cash does Axe Compute have on hand?

What is Axe Compute’s dividend yield?

Premium Investing Services